Dr Robert Marvin Erickson, DDS | |
71 South Dr, Box 26, Babbitt, MN 55706-1232 | |
(218) 827-2754 | |
Not Available |
Full Name | Dr Robert Marvin Erickson |
---|---|
Gender | Male |
Speciality | Dentist - General Practice |
Location | 71 South Dr, Babbitt, Minnesota |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1861596439 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1223G0001X | Dentist - General Practice | D10779 (Minnesota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Robert Marvin Erickson, DDS 3061 E Arm Rd, Ely, MN 55731-8451 Ph: (218) 365-4907 | Dr Robert Marvin Erickson, DDS 71 South Dr, Box 26, Babbitt, MN 55706-1232 Ph: (218) 827-2754 |
News Archive
Echo Therapeutics, Inc., a company developing its needle-free Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude SkinPrep System for transdermal drug delivery, today announced financial results for the year ended December 31, 2011.
Specific respiratory microbiome communities may be linked to influenza susceptibility, according to a study published January 9, 2019 in the open-access journal PLOS ONE by Betsy Foxman from the University of Michigan, USA, and colleagues
INTEGRA Biosciences' VOYAGER adjustable tip spacing pipette is routinely used to combat the challenges associated with repetitive pipetting tasks in molecular biology.
A new study has been published on the bioRxiv preprint server which focuses on the correlation between the vaccine-triggered Immunoglobulin G (IgG) levels and neutralization titers against SARS-CoV-2 variants. Further, neutralization activities against the variants (B.1.1.7, B.1.525, and B.1.351), using Pfizer or Moderna vaccine, sera were assessed.
› Verified 4 days ago